Introduction: This study describes the relationship between Body Mass Index (BMI) and the cardiac geometry and heart function assessed by transthoracic echocardiography.
Introduction
The prevalence of overweight and obesity is growing worldwide, constituting an epidemic that affects individuals of all ages and socioeconomic levels. In Latin America, considering both conditions, their prevalence is 40%, and in Colombia in particular, 50% [1] [2] [3] . Overweight or obese patients have persistent myocardial wall stress because of an increase in circulatory volume and minute volume, proportional to excess body weight, which occur due to increased blood flow in the adipose tissue, with minimum involvement of the heart rate at rest, but with increased systolic volume. This increase in minute volume invariably generates a compensatory increase in myocardial mass and consequent pre-clinical and clinical ventricular hypertrophy, with an eventual ventricular dilatation, with systolic and diastolic dysfunction, making up a spectrum described as cardiomyopathy of obese patients, which occur in the absence of hypertension or coronary disease 4, 5 .
On the other hand, abnormal left ventricular filling has been described in asymptomatic obese individuals that are healthy in other aspects, and a prolongation of isovolumic relaxation time. These findings can be observed in the absence of Left Ventricular systolic dysfunction (LV). Weight reduction is better associated with diastolic filling and normalization of left ventricular isovolumic relaxation time 6 . Compared with control individuals of normal weight and blood pressure, obese patients have larger left atrial (LA) and aortic root diameter and greater septal and posterior wall diastolic thickness and LV mass 7 .
The normal values of LV mass differ between men and women, even when they adjust to body surface area. The best method to normalize the LV mass measurement in adults is under discussion. Although the body surface is most often used in clinical trials, this method underestimates the prevalence of LV hypertrophy in obese and overweight people. The ability to detect the LV hypertrophy associated with obesity and cardiovascular disorders is improved by indexing the LV mass to the power of its allometric ratio (a term that refers to changes in the relative size of body segments correlated with changes in total size) to height 2.7 8 . The normal values for myocardial mass normalized by height 2.7 in obese patients have been described by the European Society of Echocardiography, and the quantification of cardiac chambers, by the American Society of Ecocardiography 9 . DOI: 10.5935/2318-8219.20150002 Hence, the objective of this study is to determine the relationship of body mass index (BMI) with cardiac geometry and function assessed by transthoracic echocardiography in a group of adults without any heart disease that would affect the measurements to be performed at Clínica Medellín (Medellin, Colombia).
Methodology
From the echocardiograms performed at the Echocardiography Service from October 2010 and February 2013, reports of patients aged between 18 and 92 years who had not limited acoustic window or any of the following diagnoses or history were taken: atrial fibrillation; presence of intraventricular electrodes; ischemic heart disease; hypertrophic cardiomyopathy; congenital heart disease; valve prostheses; chemotherapy; pericarditis; intracardiac masses or thrombi; moderate or severe stenosis or regurgitation; cor pulmonale; pulmonary thromboembolism or heart failure. The study was previously approved by the Ethics and Research Committee of Universidad CES, Medellin, Colombia.
Measurements of different echocardiographic variables were performed according to the recommendations of the American Society of Echocardiography (ASE) for the quantification of cardiac chambers. The measurements were:
• Ejection fraction through the biplane Simpson method and the Teichholz formula.
• Left ventricular mass (LVM) in grams calculated by the Devereux formula:
3 )]}+0.6, where LVEDD is the left ventricular end-diastolic diameter; IVSd is the interventricular septal dimension during diastole; and PWd is the dimension of the posterior wall during diastole.
• Left ventricular mass index (LVMI) calculated in three ways:
1) LVMI=LVM/m, where m = patient's height in meters; 2) LVMI=LVM/BS, where BS = body surface (kg/m 2 ); and 3) LVMI=LVM/height 2.7 where height 2.7 = height raised to the 2.7 power.
• Relative wall thickness (RWT), calculated as RERP = (IVSd+PWd)/LVDd where IVSd is the interventricular septal dimension during diastole; PWd is the dimension of the posterior wall during diastole; and LVDd is the left ventricular end-diastolic diameter.
• Systolic volume (SV) calculated using pulsed Doppler, obtaining the spectrum of flow velocity at the LV outflow tract (LVOT) level using apical five chamber view.
• Cardiac output (CO) as CO=0.785xD 2 xVTIxHR, where D is the diameter of the LVOT; VTI is velocity time integral in the LVOT; and HR is the heart rate in beats per minute.
• TAPSE (Tricuspid Annular Plane Systolic Excursion) measured on M mode and representing the distance that the tricuspid annulus travels from end-diastole to end-systole.
• Left atrial volume measured using the Simpson method or the ellipsoid model obtained from apical 4 and 2 chamber views; after obtaining this value and considering the differences between men and women, according to the ASE recommendations, atrial volume was indexed to body surface 9 .
Data were analyzed using Stata/SE version 12.1 (Stata Corp, College Station, 2013) accepted as significant differences with α<0.05. Qualitative variables are described as proportions and continuous variables with mean and standard deviation (SD). The number of patients allowed us to establish six groups of individuals according to BMI: 15 For each group of sex and BMI, the distribution of age and sex was established, as well as the prevalence of existing comorbidity: high systolic or diastolic blood pressure (BP) (given from blood pressure values at the time of the test), clinical history of chronic kidney failure; chronic obstructive pulmonary disease, diabetes mellitus, pulmonary hypertension and cancer. The odds ratios (OR) were calculated along with their confidence intervals of 95% (95% CI) of BMI with the presence of diabetes mellitus, systolic hypertension or diastolic hypertension.
To establish the association between BMI and echocardiographic measurements, the best multiple linear regression model was estimated, in which the primary data of each measurement correlated with the primary data of BMI and patient age, including sex, the date of the procedure and the existing comorbidity. The coefficient β was calculated and considered significant if 95% CI was positive (direct association) or negative (inverse association). In all measurements, the association between each measurement and the quadratic or cubic terms of BMI (BMI 2 or BMI 3 ) was explored according to the recommendations of Rabe-Hesketh and Skrodal 10 . The transformed data were not considered since the large number of observations (> 5,000) makes it unnecessary to do so. Finally, the multiple correlation coefficient (σ 2 ) for each model was established, as well as the graphics predicted and its confidence interval of 95%.
Results

Characteristics of the population
The original database contained 11,202 records, of which 5,304 were eliminated for various reasons (Figure 1 ). A total of 5,898 tests remained for analysis. Many of the records eliminated had more than one reason for this, and Figure 1 presents only the first reason detected that led to their removal. or systolic hypertension as well as diabetes mellitus, regardless of gender and age, which is also associated with the three conditions (Table. 3).
In Table 4 and Figures 2 to 8 , it is possible to see the average variation in the values of vital signs (blood pressure and heart rate) and echocardiographic measurements according to BMI. Only three measurements required the inclusion of a cubic term of BMI (IMC 3 ). Figure 2 shows how the two blood pressures are higher as the BMI, rather than heart rate, increases.
Left ventricular diastolic function
The maximum mitral filling E-wave velocity, which shows an ascending ratio that goes from 74 to 81 cm/s; the mitral filling A wave has a similar behavior, although with a sharper curve, presenting a greater speed as the BMI increases (Table 4 and Figure 3 ).
The finding described above is reflected in the E/A ratio, which maintains an inverse association with BMI, decreasing from 1.05 to 0.95 (β = -0.019, 95% CI -0.035 to -0.004; σ 2 = 0.2974). This decrease in E/A ratio, although minimal in quantitative terms, is statistically significant and implies an association between increased body mass and abnormal relaxation type diastolic dysfunction.
In turn, the tissue Doppler lateral e' speed decreases approximately 10 cm/s, showing a statistically significant inverse association with BMI increase (β = -0.025, 95% CI -0.152 to -0.102; σ 2 = 0.4232); this behavior does not cause any significant increase in the E/e' ration suggesting increased filling pressures, but it corroborates the relaxation disturbance (Table 4 and Figure 3 ).
Left ventricular systolic function
Left ventricular ejection fraction ranged from 61% to 64% without any significant abnormalities to the extent that BMI increased (β = 0.16, 95% CI -0.080 to 0.408; σ 2 = 0.0371), as shown in Table 4 and Figure 4 .
Cardiac output ranged from 3.9 L/min and increased to 5.5 L/min to the extent that BMI increased to 35 kg/m 2 , from which point it decreases to 5 L/min when it reaches the maximum BMI of 50 kg/m 2 ; although this increase shows a statistically significant direct association with BMI (β = 0.16, 95% CI 0.109 to 0.331), this behavior is not explained by this variable only, but also by the male gender. These two covariates explain only 5% of the cardiac output increasing trend (σ 2 = 0.0447).
Ejection volume in turn presents a behavior similar to cardiac output, with an increment proportional to BMI increase, reaching 73 mL for a BMI of 37 kg/m 2 , and decreasing to 69 mL with a BMI of 50 kg/m 2 , being a statistically significant direct association (β = 2.7, 95% CI 1.23 to 4.18; σ 2 = 0.0215).
Left atrium
Two left atrial measurement variables were analyzed: left atrial volume area and index (Table 4 shows a statistically significant direct association with BMI (β = 0.456, 95% CI 0.097 to 0.815; σ 2 = 0.13).
Left ventricular systolic function
The systolic excursion of the tricuspid annulus (TAPSE) increases from 20.5 mm to 22.5 mm with BMI, being a direct and significant association (β = 0.023, 95% CI 0.006 to 0.039; σ 2 = 0.0609). The tissue Doppler S-wave velocity shows an inverse association (β = -0.096, 95% CI -0.222 to -0.031; σ 2 = 0.0453). These findings were not relevant to the interpretation of right ventricular systolic function (Table 4 and Figure 6 ).
Left ventricular geometry
The evaluation of ventricular geometry requires the ratio of relative wall thickness and left ventricular mass index (Table 4 and Figure 7 ). The relative wall thickness increases from 0.37 to 0.43 to achieve a BMI of 33 kg/m . This increase in myocardial mass has a statistically significant direct association with BMI (β = 13.41, 95% CI 8.74 to 18.08; σ 2 = 0.027). This indicates that although the myocardial mass is influenced by the increase in BMI, this is not the only influencing factor; in fact, only 3% of this behavior can be explained by the male gender. By indexing ventricular mass by body surface area, there is a progressive increase in left ventricular mass index ranging from 30 to 35 kg/m 2 of BMI, reaching a maximum rate of left ventricular mass of 90 gr/m 2 , from which it decreases. The progressive increase of 75 to 90 gr/m 2 has a statistically significant direct association with BMI (β = 5.2, 95% CI 2.49 to 7.89; σ 2 = 0.0123). To reduce the effect of obesity with an estimated left ventricular mass, its normalization was performed by the height to the power 2.7, also showing a progressive increase in left ventricular mass indexed to the extent that the mass body is increased, reaching a maximum of 1.1 and 50 g/m 2.7 , respectively, with body mass index of 36 kg/m 2 . In both cases, there is a direct association (β = 0.082, 95% CI 0.053 to 0.111; σ 2 = 0.0220 for height and β = 3.57, 95% CI 2.22 to 4.92; σ 2 = 0.0190 for height indexation 2.7 ). Although in both cases there was a direct association, by indexing to height 2.7 we obtains a better coefficient β (3.57 vs. 0.082), revealing a significant increase in left ventricular mass index above the values currently accepted as normal (women: 18-44 gr/m 2.7 ; and men: 20-48 gr/m 2.7 ) to the extent that the BMI increases. This increase is identified from overweight, noting an increased ventricular mass in patients with a BMI of 26 kg/m 2 (Table 4 and Figure 6 ).
Discussion
Obesity is an important risk factor for the development of cardiovascular diseases. After dividing the population object of study according to the BMI and according to the WHO classification, it was observed that to the extent that body mass increased, the prevalence of hypertension and diabetes mellitus significantly increased (Tables 2 and 3) , as previously described in the literature by Guh et al. which, in a review and meta-analysis described the incidence of comorbidities associated with overweight and obesity [1] [2] [3] . Pascual et al., in a paper dealing with the effects of obesity on systolic and diastolic left ventricular function, reported that obese individuals have an increased circulating blood volume that generates an increase in cardiac output, leading to ventricular dilatation and eccentric left ventricular hypertrophy. It has also been shown that myocardial fat infiltration affects not only the ventricular structure but also the ventricular mechanics [11] [12] [13] [14] . This increase in circulating volume was corroborated in this study with a statistically significant direct association between cardiac output, ejection volume and body mass index, identifying a maximum value when mass index reaches 35 and 37 kg/m 2 , respectively.
Left ventricular systolic function did not vary in relation to body mass; ejection fraction remained within normal limits in all groups; these findings are similar to those described in other studies in which no significant variations in ejection fraction of obese patients were described 11, 15 .
In the study of the impact of body mass index on left ventricular diastolic dysfunction, Cil et al. 16 describe an E-wave significantly lower in the groups with BMI > 25 kg/m 2 , while A and A' septal waves were significantly higher in these groups. Similarly, the E/e' ratio was significantly higher in groups of patients with overweight and obesity than in those with BMI < 25 kg/m 2 16 . Regarding the diastolic function in this study, there was an inverse association between the E/A ratio and BMI (β = -0.019, 95% CI -0.035 to -0.004; σ 2 = 0.2974), which is a slight, yet statistically significant decrease from 1.05 to 0.95, and also an inverse association between the tissue Doppler lateral e' velocity and increased BMI (β = -0.025, 95% CI -0.152 to -0.102; σ 2 = 0.4232), showing a diastolic dysfunction predominantly of abnormal relaxation type to the extent that body mass increases. These findings corroborate the findings in the literature, in which increased BMI is a predictor of left ventricular diastolic dysfunction, regardless of age, hypertension and diabetes mellitus 11, 16, 17 . Neither did the study demonstrate an association between BMI and increased lateral E/e' ratio nor septal E/e' ratio that could be associated with increased filling pressures in overweight or obese patients.
Consistently with the study "Cardiac Remodeling and Obesity" by Ashrafian et al. 7 , a slight yet significant increase in the left atrial indexed area and volume was demonstrated to the extent that body mass increased. The variables for the assessment of right ventricular systolic and diastolic function showed no relevant changes related to body mass index, which is consistent with the literature, which describes that the right ventricular function is neither affected by overweight or obesity 12, 18 . In a study by Movahed et al. 19 on obesity in adolescents, the association between obesity, hypertension and left ventricular hypertrophy was assessed. A total of 2,072 individuals were assessed for the presence of left ventricular hypertrophy and hypertension (defined as systolic blood pressure > 140 mmHg and diastolic blood pressure > 90 mmHg) and obesity as BMI > 30 kg/m 2 . Using a multivariate analysis adjusted for age, gender and blood pressure, obesity remains strongly associated with left ventricular hypertrophy (OR 4.51, 95% CI 2.83 to 7.19, p < 0.001).
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In this study, 5,898 records were reviewed and through a model of multiple linear regression, raw data of BMI correlated with myocardial mass and myocardial mass indexed to body surface area, finding a statistically significant direct association between overweight (BMI 25-29, 9 kg/m 2 ), obesity (BMI > 30 kg/m 2 ) and increased left ventricular mass (β = 13, 41, 95% CI 8, 74 to 18, 08). When the mass was indexed, this direct association persisted, although smaller β 5,2 . In the previous variables, increased myocardial mass has not reached any values that could be correlated with left ventricular hypertrophy, and this phenomenon is accentuated when the mass is adjusted for body surface area. In addition, it is observed that once a BMI ≥ 35 kg/m 2 is reached, myocardial mass and myocardial mass index decreases proportionally. This could indicate that in patients with BMI ≥ 35 kg/m 2 , by indexing myocardial mass to body surface area, the true effect of obesity (especially grades II and III) on myocardial mass and ventricular geometry is underestimated. De Simone et al. 8 demonstrated that the normalization of left ventricular mass by body surface area and length introduces artifacts related to the indexation of left ventricular mass to body mass and errors in estimating the impact of overweight. From this analysis, it was decided to index the myocardial mass to height 2.7 . In both cases, there was a direct association between increased myocardial mass and the body mass; however, by indexing ventricular mass to height 2.7 there was a stronger association (β 3:57 vs. 0.082), revealing a significant increase in left ventricular mass index above the normal currently accepted values 9 , to the same extent that the body mass index increases, in which case there is a statistically significant direct association between obesity and left ventricular hypertrophy, once the interference generated by indexing to body mass is eliminated (Figure 8) The relative wall thickness also has a direct association with increased body mass, increasing from 0.37 to 0.42, a value that is reached with a BMI of 26 kg/m 2 and rises to 0.43 when body mass index reaches 30 kg/m 2 , with a subsequent decrease to 0.34 insofar as it continues its increase. Taking into account that there is an association between overweight, obesity and left ventricular hypertrophy, this increase in relative wall thickness could explain an initial concentric increase in myocardial mass in overweight patients, but to the extent that overweight obesity becomes hypertrophy, concentric hypertrophy becomes eccentric hypertrophy (Figures 7 and 8) . Rider et al. 20 showed in a study with 88 female individuals, not diabetic or hypertensive, that a slight increase in BMI from normal to overweight results in eccentric myocardial hypertrophy with no expected changes dependent on the volume that lead to myocardial dilatation. The same authors suggest that early hypertrophic abnormalities are secondary to hyperleptinemia, and subsequent left ventricular dilation seen in morbid obesity is probably induced by hypervolemia. This is consistent with the direct association described in this study, increased body mass with increasing ejection volume and cardiac output and decrease of relative wall thickness and myocardial mass index to the extent that BMI ≥ 34 and 38 kg/m 2 , respectively. These findings are similar to the findings of Palmieri and De Simone in the study of various degrees of body mass index in hypertensive patients compared with left ventricular mass, cardiac output and peripheral resistance 21 .
This study established the coefficient of multiple correlation for each of the models, demonstrating that although overweight and obesity are factors that determine a significant increase in myocardial mass, when there is a statistically significant direct association, they are not the only factors affecting it. The covariate male gender also showed a direct association with increased myocardial mass and comorbidities such as systolic and diastolic hypertension and diabetes mellitus were more prevalent among overweight and obese patients, which in previous studies have been significantly and independently related with left ventricular hypertrophy [22] [23] [24] .
Conclusions
This study showed a significant direct association between increased BMI and increased myocardial mass. By indexing myocardial mass to height 2.7 we avoid those effects related to normalization for body mass index (ASC) in which the impact of increased body mass on ventricular geometry is underestimated, showing a direct relationship between overweight and obesity with left ventricular hypertrophy. Hence, indexing ventricular mass to height 2.7 is recommended, especially in patients with grade II and III obesity. Considering the behavior of relative wall thickness and myocardial mass, it was confirmed that left ventricular hypertrophy appears from overweight, originally concentric and, to the extent that body mass increases, it becomes eccentric. The description of other authors, who demonstrate a significant increase in cardiac output and ejection volume when body mass is increased, resulting from increased circulating volumes in obese people, is also corroborated.
There was an inverse association between increased body mass and the E/A ratio of mitral filling, with a statistically significant decrease in the tissue Doppler lateral e' speed as BMI increases, showing am abnormal relaxation-type diastolic dysfunction in overweight and obese individuals. There was no increase in the E/e' ratio that could make one assume any increase in filling pressures.
The study also demonstrated a discreet yet significant increase in the left atrial indexed area and volume to the extent that body mass increases.
This study confirms, to a great extent, what has been previously described in the literature and brings new useful knowledge for understanding the effect that overweight and obesity have on cardiac structure and function. Although there are methodological limitations of studies based on records, the important size of the sample analyzed and significant findings demonstrate their relevance.
